Q2 2020 13F Holders as of 6/30/2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
124M
-
Number of holders
-
249
-
Total 13F shares, excl. options
-
133M
-
Shares change
-
+7.12M
-
Total reported value, excl. options
-
$3.57B
-
Value change
-
+$197M
-
Put/Call ratio
-
0.26
-
Number of buys
-
153
-
Number of sells
-
-80
-
Price
-
$26.81
Significant Holders of HALOZYME THERAPEUTICS, INC. - Common Stock (HALO) as of Q2 2020
283 filings reported holding HALO - HALOZYME THERAPEUTICS, INC. - Common Stock as of Q2 2020.
HALOZYME THERAPEUTICS, INC. - Common Stock (HALO) has 249 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 133M shares
.
Largest 10 shareholders include Artisan Partners Limited Partnership (16.8M shares), BlackRock Inc. (13.2M shares), VANGUARD GROUP INC (13M shares), Bellevue Group AG (6.73M shares), WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (6.58M shares), STATE STREET CORP (5.23M shares), JPMORGAN CHASE & CO (4.96M shares), Invesco Ltd. (3.68M shares), Third Security, LLC (3.52M shares), and SNYDER CAPITAL MANAGEMENT L P (3.4M shares).
This table shows the top 249 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.